See also this year's filing and all EDGAR filings for this company.
PDF Report 0001514946_2023_AXIM_BIOTECHNOLOGIES_INC.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001514946, AXIM BIOTECHNOLOGIES INC.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 103,979 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 93,840 |
| 3 | remainder_Assets | 4,014,216 |
| 4 | LiabilitiesCurrent | 3,392,494 |
| 5 | LiabilitiesNoncurrent | 5,644,953 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 4,081,824 |
| 9 | ResearchAndDevelopmentExpense | 153,697 |
| 10 | remainder_Expenses | 426,126 |
| 11 | remainder_Revenues | 8,875 |
| 12 | remainder_NetIncome | 1,590,177 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 4,212,035 |
| 1 | Liabilities | 9,037,447 |
| 2 | Expenses | 4,661,647 |
| 3 | Revenues | 8,875 |
| 4 | StockholdersEquity | -4,825,412 |
| 5 | NetIncome | -3,062,595 |
| 6 | ComprehensiveNetIncome | -3,062,595 |
| 7 | BaseVar | 9,755,090 |
| 8 | EconomicCapitalRatio | -1.72 |